National Breast Cancer and Lymphedema Registry

Stanley Rockson

Status: Terminated

Conditions: Breast Cancer; Lymphedema

Study type: Observational

Funder types: Other

Identifiers

NCT01580800

SU-10042011-8529

22349 (Other Identifier)

Details and patient eligibility

About

The purpose of the National Breast Cancer Lymphedema Registry is to collect health information in order to study the lymphedema as a complication of breast cancer treatment. The investigators hope to learn whether early diagnosis will help to prevent lymphedema or, if it does occur, to reduce the severity.

Full description

Historically, breast cancer-associated lymphedema has been relatively ignored, with mis-diagnosis, late diagnosis, and failure to treat. The condition has a measurable, substantial impact on patient function and perceived quality of life (QOL). Recent pilot studies suggest that interventions that are designed to facilitate early diagnosis and preventive strategies have a major impact on the incidence and severity of disease burden. This registry is designed to prospectively capture the relevant data to document the impact of preemptive diagnostic and treatment strategies.

Enrollment: 549 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Breast cancer survivorship

Exclusion criteria

• Age < 18 years old

Trial design

549 participants in 1 patient group

Breast cancer survivors

Description:

Patients who have undergone breast cancer treatment (e.g. surgery, node dissection, chemotherapy and/or radiation therapy), and what affect this has had on their arm health.